Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-002070
Accepted
2025-06-30 00:15:34
Documents
1
Effectiveness Date
2025-06-27

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 599
  Complete submission text file 9999999995-25-002070.txt   1769
Mailing Address 1000 N. WEST STREET, SUITE 1200 WILMINGTON DE 19801
Business Address 1000 N. WEST STREET, SUITE 1200 WILMINGTON DE 19801 (302) 295-3800
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

EIN.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-288213 | Film No.: 251088626
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)